Who Paid My Doc
Abigail Tepper
Registered Nurse, Oncology Durham, NC Nurse Practitioner
NPI 1407511934 CMS profile 11264968
2301 Erwin Rd, Durham, NC 27705
General payments
$75
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Abigail Tepper of Durham, NC is reported in the CMS Open Payments database as having received $75 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $75 | 1 |
Beside peers
- Abigail Tepper
- Registered Nurse, Oncology median
- Middle half of Registered Nurse, Oncology
- National median
In program year 2025, general payments to Abigail Tepper were reported at $75. Among 46 Registered Nurse, Oncology profiles paid that year, the median was $118 and the middle half received between $60 and $222.
Show as a table
| Year | Abigail Tepper | Registered Nurse, Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $0 | $120 | $42–$385 | $149 |
| 2023 | $0 | $120 | $50–$439 | $160 |
| 2024 | $0 | $172 | $61–$635 | $164 |
| 2025 | $75 | $118 | $60–$222 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
14
Drug cost
$159
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Acyclovir | Generic | 14 | $159 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$2,032
Medicare patients
25
Services billed
39
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 52% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Registered Nurse, Oncology in North Carolina
Related records
Registered Nurse, Oncology in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Registered Nurse, Oncology
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.